441 related articles for article (PubMed ID: 26147609)
1. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
2. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs.
Eschbacher JM; Coons SW
Endocr Pathol; 2006; 17(4):365-76. PubMed ID: 17525485
[TBL] [Abstract][Full Text] [Related]
4. Surgical pathology of the pituitary in Cushing's disease.
Saeger W
Pathol Res Pract; 1991 Jun; 187(5):613-6. PubMed ID: 1656411
[TBL] [Abstract][Full Text] [Related]
5. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.
Zhu D; Wang Z; Tian T; Wu X; He D; Zhu Y; Liu D; Wang H
Front Endocrinol (Lausanne); 2022; 13():947085. PubMed ID: 36060980
[TBL] [Abstract][Full Text] [Related]
7. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
[TBL] [Abstract][Full Text] [Related]
8. Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.
Akirov A; Larouche V; Shimon I; Asa SL; Mete O; Sawka AM; Gentili F; Ezzat S
Front Endocrinol (Lausanne); 2021; 12():620005. PubMed ID: 33815279
[TBL] [Abstract][Full Text] [Related]
9. Current status on histological classification in Cushing's disease.
Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K
Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318
[TBL] [Abstract][Full Text] [Related]
10. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
Taylor HC; Velasco ME; Brodkey JS
Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859
[TBL] [Abstract][Full Text] [Related]
11. Pituitary pathology in Cushing's disease.
Saeger W; Geisler F; Lüdecke DK
Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
13. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma.
Kovacs K; Diep CC; Horvath E; Cusimano M; Smyth H; Lombardero CC; Scheithauer BW; Lloyd RV
Can J Neurol Sci; 2005 Nov; 32(4):540-5. PubMed ID: 16408589
[TBL] [Abstract][Full Text] [Related]
14. Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing's disease.
Flitsch J; Lüdecke DK; Knappe UJ; Saeger W
Exp Clin Endocrinol Diabetes; 1999; 107(3):183-9. PubMed ID: 10376443
[TBL] [Abstract][Full Text] [Related]
15. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
George DH; Scheithauer BW; Kovacs K; Horvath E; Young WF; Lloyd RV; Meyer FB
Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
[TBL] [Abstract][Full Text] [Related]
16. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
17. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease.
Hague K; Post KD; Morgello S
Surg Neurol; 2000 Jan; 53(1):77-81. PubMed ID: 10697237
[TBL] [Abstract][Full Text] [Related]
18. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Kurowska M; Tarach JS; Malicka J; Zieliński G; Maksymowicz M; Denew P
Endokrynol Pol; 2016; 67(5):526-533. PubMed ID: 27828691
[TBL] [Abstract][Full Text] [Related]
19. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Takeshita A; Inoshita N; Taguchi M; Okuda C; Fukuhara N; Oyama K; Ohashi K; Sano T; Takeuchi Y; Yamada S
Eur J Endocrinol; 2009 Oct; 161(4):553-9. PubMed ID: 19589911
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
